Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heterologous Prime-boost-boost Vaccine Combinations for Long-term Humoral and Cellular Immunity Against COVID-19

NCT05142319 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT05142319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heterologous Prime-boost-boost Vaccine Combinations for Long-term Humoral and Cellular Immunity Against COVID-19
Lead sponsor
Tan Tock Seng Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 12, 2021
Completion date
May 7, 2024
Enrollment
326 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19